Sodium dichloroacetate

Overview

Sodium dichloroacetate is an orally active pyruvate dehydrogenase kinase ( PDK ) inhibitor. Sodium dichloroacetate also stimulates pyruvate dehydrogenase ( PDH ) activity and works as a Na + -K + -2Cl − cotransporter ( NKCC ) inhibitor. Sodium dichloroacetate prevents the phosphorylation of the E1α subunit of PDC, promoting the entry of pyruvate into the mitochondria for oxidative metabolism, reducing lactate production, and simultaneously increasing the production of reactive oxygen species (ROS). Sodium dichloroacetate inhibits tumor cell proliferation and induces apoptosis . Sodium dichloroacetate is promising for research of cancers.

Application

Products | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > PDHK | Products > Signaling Pathways > Reactive Oxygen Species (ROS) | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > PDK-1 | Products > Signaling Pathways > NKCC

Product Information

• Catalog No.: HY-Y0445A
• CAS No.: 2156-56-1
• Molecular Formula: C2HCl2NaO2
• Molecular Weight: 150.92
• Purity: 99.78%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: 100 mg/mL (662.60 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source